Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

Research output: Contribution to journal › Article › peer-review

Cite this

@article{1f162e067d28404397b12caa4488be75,

title = "Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial",

author = "Minesh Mehta",

note = "Neuro-Oncology (2022) 25(2):339–350",

year = "2023",

month = feb,

day = "14",

language = "American English",

volume = "25",

journal = "Neuro-oncology",

}